NicOx Reports Positive Data for Cholesterol Drug
NicOx announced that NCX 6560, its drug candidate for high cholesterol, met its primary and secondary endpoints in a Phase Ib man-in study.
lipitor
Brocair Publishes New Report on Generics Market
Brocair Partners LLC, an investment bank serving the healthcare industry, has published a new report on the generic pharmaceuticals sector.